EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Zeo ScientifiX's enterprise value is $12.80 Mil.
Zeo ScientifiX's EBITDA for the trailing twelve months (TTM) ended in Jan. 2025 was $-4.75 Mil. Therefore, Zeo ScientifiX's EV-to-EBITDA for today is -2.70.
The historical rank and industry rank for Zeo ScientifiX's EV-to-EBITDA or its related term are showing as below:
ZEOX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -639.03 Med: -4.11 Max: -0.08
Current: -2.7
During the past 13 years, the highest EV-to-EBITDA of Zeo ScientifiX was -0.08. The lowest was -639.03. And the median was -4.11.
ZEOX's EV-to-EBITDA is ranked worse than 100% of 501
companies
in the Biotechnology industry
Industry Median: 7.89
vs ZEOX: -2.70
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Zeo ScientifiX EV-to-EBITDA Historical Data
The historical data trend for Zeo ScientifiX's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zeo ScientifiX's EV-to-EBITDA
For the Biotechnology subindustry, Zeo ScientifiX's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's EV-to-EBITDA falls into.
Zeo ScientifiX's current Enterprise Value is $12.80 Mil.
Zeo ScientifiX's EBITDA for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zeo ScientifiX's PE Ratio (TTM) for today is calculated as:
Zeo ScientifiX's share price for today is $1.97.
Zeo ScientifiX's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Zeo ScientifiX's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZEOX has been successfully added to your 